These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 11724950)

  • 21. Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with
    Ebadi Sharafabad B; Abdoli A; Panahi M; Abdolmohammadi Khiav L; Jamur P; Abedi Jafari F; Dilmaghani A
    Adv Pharm Bull; 2023 Nov; 13(4):817-826. PubMed ID: 38022809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.
    Dailey KM; Small JM; Pullan JE; Winfree S; Vance KE; Orr M; Mallik S; Bayles KW; Hollingsworth MA; Brooks AE
    PLoS One; 2023; 18(11):e0289183. PubMed ID: 37963142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer.
    Li Z; Fallon J; Mandeli J; Wetmur J; Woo SL
    J Natl Cancer Inst; 2008 Oct; 100(19):1389-400. PubMed ID: 18812551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Microenvironment Targeting Nano-Bio Emulsion for Synergistic Combinational X-Ray PDT with Oncolytic Bacteria Therapy.
    Park W; Cho S; Kang D; Han JH; Park JH; Lee B; Lee J; Kim DH
    Adv Healthc Mater; 2020 Jul; 9(13):e1901812. PubMed ID: 32529747
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Staedtke V; Roberts NJ; Bai RY; Zhou S
    Genes Dis; 2016 Jun; 3(2):144-152. PubMed ID: 30258882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI-monitored intra-tumoral injection of iron-oxide labeled Clostridium novyi-NT anaerobes in pancreatic carcinoma mouse model.
    Zheng L; Zhang Z; Khazaie K; Saha S; Lewandowski RJ; Zhang G; Larson AC
    PLoS One; 2014; 9(12):e116204. PubMed ID: 25549324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spore coat architecture of Clostridium novyi NT spores.
    Plomp M; McCaffery JM; Cheong I; Huang X; Bettegowda C; Kinzler KW; Zhou S; Vogelstein B; Malkin AJ
    J Bacteriol; 2007 Sep; 189(17):6457-68. PubMed ID: 17586633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A bacterial protein enhances the release and efficacy of liposomal cancer drugs.
    Cheong I; Huang X; Bettegowda C; Diaz LA; Kinzler KW; Zhou S; Vogelstein B
    Science; 2006 Nov; 314(5803):1308-11. PubMed ID: 17124324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo.
    Theys J; Pennington O; Dubois L; Anlezark G; Vaughan T; Mengesha A; Landuyt W; Anné J; Burke PJ; Dûrre P; Wouters BG; Minton NP; Lambin P
    Br J Cancer; 2006 Nov; 95(9):1212-9. PubMed ID: 17024128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial targeted tumour therapy-dawn of a new era.
    Wei MQ; Mengesha A; Good D; Anné J
    Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RELATIONSHIP BETWEEN TOXIGENICITY AND SPORULATING POTENCY OF CLOSTRIDIUM NOVYI.
    NISHIDA S; NAKAGAWARA G
    J Bacteriol; 1965 Apr; 89(4):993-5. PubMed ID: 14279120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protective effect of Clostridium novyi type B alpha-toxoid against challenge with spores in guinea pigs.
    Amimoto K; Sasaki O; Isogai M; Kitajima T; Oishi E; Okada N; Yasuhara H
    J Vet Med Sci; 1998 Jun; 60(6):681-5. PubMed ID: 9673937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil depletion enhanced the
    Staedtke V; Gray-Bethke T; Liu G; Liapi E; Riggins GJ; Bai RY
    Neurooncol Adv; 2022; 4(1):vdab184. PubMed ID: 35118381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response to C. novyi-NT immunotherapy.
    DeClue AE; Axiak-Bechtel SM; Zhang Y; Saha S; Zhang L; Tung D; Bryan JN
    Vet Res; 2018 Apr; 49(1):38. PubMed ID: 29690928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth retardation and prevention of Ehrlich solid tumor by Clostridium perfringens type A spores and culture supernatant.
    Lapointe JR; Portelance V
    Cancer Res; 1978 Aug; 38(8):2295-300. PubMed ID: 208766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discodermolide analogues as the chemical component of combination bacteriolytic therapy.
    Smith AB; Freeze BS; LaMarche MJ; Sager J; Kinzler KW; Vogelstein B
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3623-6. PubMed ID: 15979874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium to treat cancer: dream or reality?
    Theys J; Lambin P
    Ann Transl Med; 2015 May; 3(Suppl 1):S21. PubMed ID: 26046067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor tissue recycling--a new combination treatment for solid tumors: experimental and preliminary clinical research.
    Li B; Ding J; Larson A; Song S
    In Vivo; 1999; 13(5):433-8. PubMed ID: 10654199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium novyi exhibits antitumor effect in mice transplanted with H22 hepatocarcinoma by down-regulation of hypoxia-inducible factor-1α.
    Huang XJ; Yang Y; Deng ZM; Kuang Y; Shi H; Li WY; Li MY
    J Biol Regul Homeost Agents; 2020; 34(6):2159-2164. PubMed ID: 33225677
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.